LEEANNE VANDEGRIFF: Open Payments
NPI 1760074470 · FORT WORTH, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,806 in 81 payments from 39 companies in 2025. Trend: 2023 $2,052 · 2024 $2,547 · 2025 $2,806
Food & beverage: $2,806
| Company | Payments | Amount |
|---|---|---|
| Daiichi Sankyo Inc. | 9 | $284 |
| Janssen Biotech, Inc. | 4 | $262 |
| Gilead Sciences, Inc. | 3 | $165 |
| Sirtex Medical Inc | 2 | $161 |
| AstraZeneca Pharmaceuticals LP | 7 | $158 |
| Genmab U.S., Inc. | 2 | $146 |
| Geron Corporation | 3 | $131 |
| Stemline Therapeutics Inc. | 2 | $124 |
| PUMA BIOTECHNOLOGY, INC. | 1 | $121 |
| ADC THERAPEUTICS AMERICA, INC. | 1 | $113 |
Products named: SIR-Spheres Microspheres, RYTELO, Tivdak, Orserdu, NERLYNX, RYBREVANT, ZYNLONTA, Vanflyta.
Industry payments across TX — which companies pay providers there.
